Ketogenic diet in cancer management

Talib, Wamidh H.; Al-Dalaeen, Anfal; Mahmod, Asma Ismail

doi:10.1097/mco.0000000000000944

Cited by 4 publications

(1 citation statement)

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Notably, various forms of the KD have been developed to address different clinical demands, ranging from body weight management to neurological disorders, while recent research has shed light on the potential cardiovascular benefits of a KD [ 5 , 7 , 8 ]. Emerging evidence has suggested that the metabolic and neurobiological effects of the KD extend beyond seizure control, offering potential advantages for cardiovascular health, cancer treatment, and inflammation reduction, while also impacting various aspects of brain function and mental well-being [ 9 , 10 , 11 , 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder: From the Basic Research to the Clinical Practice

Chrysafi,

Jacovides,

Papadopoulou

et al. 2024

Nutrients

View full text Add to dashboard Cite

Background: The ketogenic diet (KD) has been highly developed in the past for the treatment of epileptic pathological states in children and adults. Recently, the current re-emergence in its popularity mainly focuses on the therapy of cardiometabolic diseases. The KD can also have anti-inflammatory and neuroprotective activities which may be applied to the prevention and/or co-treatment of a diverse range of psychiatric disorders. Purpose: This is a comprehensive literature review that intends to critically collect and scrutinize the pre-existing research basis and clinical data of the potential advantageous impacts of a KD on stress, anxiety, depression, schizophrenia and bipolar disorder. Methods: This literature review was performed to thoroughly represent the existing research in this topic, as well as to find gaps in the international scientific community. In this aspect, we carefully investigated the ultimate scientific web databases, e.g., PubMed, Scopus, and Web of Science, to derive the currently available animal and clinical human surveys by using efficient and representative keywords. Results: Just in recent years, an increasing amount of animal and clinical human surveys have focused on investigating the possible impacts of the KD in the prevention and co-treatment of depression, anxiety, stress, schizophrenia, and bipolar disorder. Pre-existing basic research with animal studies has consistently demonstrated promising results of the KD, showing a propensity to ameliorate symptoms of depression, anxiety, stress, schizophrenia, and bipolar disorder. However, the translation of these findings to clinical settings presents a more complex issue. The majority of the currently available clinical surveys seem to be moderate, usually not controlled, and have mainly assessed the short-term effects of a KD. In addition, some clinical surveys appear to be characterized by enormous dropout rates and significant absence of compliance measurement, as well as an elevated amount of heterogeneity in their methodological design. Conclusions: Although the currently available evidence seems promising, it is highly recommended to accomplish larger, long-term, randomized, double-blind, controlled clinical trials with a prospective design, in order to derive conclusive results as to whether KD could act as a potential preventative factor or even a co-treatment agent against stress, anxiety, depression, schizophrenia, and bipolar disorder. Basic research with animal studies is also recommended to examine the molecular mechanisms of KD against the above psychiatric diseases.

show abstract

Section: Introductionmentioning

confidence: 99%

The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder: From the Basic Research to the Clinical Practice

Chrysafi,

Jacovides,

Papadopoulou

et al. 2024

Nutrients

View full text Add to dashboard Cite

show abstract

Common and divergent molecular mechanisms of fasting and ketogenic diets

Paoli,

Tinsley,

Mattson

et al. 2024

Trends in Endocrinology & Metabolism

View full text Add to dashboard Cite

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer

Liu,

Zhang,

Wang

et al. 2024

Mol Cancer

View full text Add to dashboard Cite

Metabolic alterations, a hallmark of cancer, enable tumor cells to adapt to their environment by modulating glucose, lipid, and amino acid metabolism, which fuels rapid growth and contributes to treatment resistance. In primary breast cancer, metabolic shifts such as the Warburg effect and enhanced lipid synthesis are closely linked to chemotherapy failure. Similarly, metastatic lesions often display distinct metabolic profiles that not only sustain tumor growth but also confer resistance to targeted therapies and immunotherapies. The review emphasizes two major aspects: the mechanisms driving metabolic resistance in both primary and metastatic breast cancer, and how the unique metabolic environments in metastatic sites further complicate treatment. By targeting distinct metabolic vulnerabilities at both the primary and metastatic stages, new strategies could improve the efficacy of existing therapies and provide better outcomes for breast cancer patients. Supplementary Information The online version contains supplementary material available at 10.1186/s12943-024-02165-x.

show abstract

Ketogenic diet in cancer management

Cited by 4 publications

References 49 publications

The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder: From the Basic Research to the Clinical Practice

The Potential Effects of the Ketogenic Diet in the Prevention and Co-Treatment of Stress, Anxiety, Depression, Schizophrenia, and Bipolar Disorder: From the Basic Research to the Clinical Practice

Common and divergent molecular mechanisms of fasting and ketogenic diets

Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer

Contact Info

Product

Resources

About